<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>315023</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>7493916</PubmedId>
            <Abstract>Naturally processed self-peptides bound to human histocompatibility leukocyte antigens (HLA) class I molecules of human hepatocellular carcinoma tissues (HLA-A2.1, -B44, -B13) in vivo were isolated for sequence analysis. Acid-eluted peptides were subjected to reversed-phase high-performance liquid chromatographic separation and single-fraction sequencing was performed by Edman degradation. The peptides were found to be octamers or nonamers and they were derived from the processing of intracellular proteins. Three independent sequences were obtained from HLA-A2.1 molecules. One of the peptides showed sequence homology to the hepatitis B virus (HBV) pre-S protein, one to aldehyde dehydrogenase, and the other to no known protein. Two independent sequences were obtained from HLA-B44, B13 molecules: one showed sequence homology to the human c-abl protein, the other showed no homology to any known protein. A synthetic biotinylated peptide based on the HBV pre-S peptide sequence was confirmed to bind to HLA-A2.1 gene-transfected L cells. These data suggested that peptides potentially recognized by cytotoxic T cells can bind to HLA class I molecules on tumor cells in vivo.</Abstract>
            <ArticleYear>1995</ArticleYear>
            <ArticlePages>962-8</ArticlePages>
            <ArticleTitle>Analysis of naturally processed human histocompatibility leukocyte antigen class I-bound peptides from hepatocellular carcinoma tissues in vivo.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kobayashi</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Sato</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Miyokawa</LastName>
                    <ForeName>N</ForeName>
                </Author>
                <Author>
                    <LastName>Kimura</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Nakashima</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Katagiri</LastName>
                    <ForeName>M</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Pathology, Asahikawa Medical College.</Affiliations>
            <ArticleChemicalList>Histocompatibility Antigens Class I;Peptides</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Carcinoma, Hepatocellular(immunology); Histocompatibility Antigens Class I(chemistry); Humans; Liver Neoplasms(immunology); Molecular Sequence Data; Peptides(chemistry); Protein Binding</ArticleMeshHeadingsList>
            <Comments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/)</Comments>
            <Journal>
                <Volume>86</Volume>
                <Issue>10</Issue>
                <Title>Japanese journal of cancer research : Gann</Title>
                <Issn>0910-5050</Issn>
                <MedlineTa>Jpn J Cancer Res</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HB-1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>STNRQSGRQ</LinearSequence>
                        <StartingPosition>96</StartingPosition>
                        <EndingPosition>104</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAQ81917.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10407</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Materials and Methods</LocationOfData>
                <EpitopeId>61798</EpitopeId>
                <ReferenceStartingPosition>141</ReferenceStartingPosition>
                <ReferenceEndingPosition>149</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The following refers to the epitope id as found in the original FIMM database: P000021.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5</LocationOfData>
                        <MhcBindingId>1349456</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HB-2</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>STDRQSGRQ</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Materials and Methods</LocationOfData>
                <EpitopeId>61562</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This peptide is an analog of the Hepatitis B virus pre-S p141-149 epitope.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 5</LocationOfData>
                        <MhcBindingId>1349457</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

